CD33 MicroBeads have been developed for separation of cells based on the expression of the CD33 antigen. CD33+ cells can be enriched from PBMCs, bone marrow¹,², or tissues.³
Related products for CD33 MicroBeads, human
CD33 MicroBeads have been developed for separation of cells based on the expression of the CD33 antigen. CD33+ cells can be enriched from PBMCs, bone marrow¹,², or tissues.³
The CD33 antigen is brightly expressed on monocytes and dimly on granulocytes and dendritic cells. The CD33 antigen is also found on myeloid progenitor cells but is not expressed on lymphocytes, platelets, erythrocytes, and primitive hematopoietic stem cells.
CD33+ cells can be enriched from PBMCs, bone marrow1,2, or tissues.3 Additionally, the CD33 antigen can be used to distinguish acute myeloid leukemias from lymphoblastic leukemias.
For positive selection: MS, LS, XS, or autoMACS® Columns. For depletion: LD, D, or autoMACS Columns.
Separation of CD33+ cells from human PBMCs using CD33 MicroBeads, a MiniMACS™ Separator, and an MS Column. Cells are fluorescently stained with CD33-PE and CD14-APC.
- Rogler, G. et al. (1998) Isolation and phenotypic characterization of colonic macrophages. Clin. Exp. Immunol. 112: 205-215
- Czerniecki, B. J. et al. (1997) Calcium ionophore-treated peripheral blood monocytes and dendritic cells rapidly display characteristics of activated dendritic cells. J Immunol 159: 3823-3837
- Gonzalez, R. et al. (1999) Transduction of bone marrow cells by the AdZ.F(pK7) modified adenovirus demonstrates preferential gene transfer in myeloma cells. Hum. Gene Ther. 10: 2709-2717
You have previously chosen International as your location.
What do you want to do?